List of Patents

« Back

PPAR-alpha/gamma AGONISTS

PPAR-alpha/gamma AGONISTS

PPAR-alpha/gamma AGONISTS

Researchers from INCLIVA has synthesised a novel family of drug candidates with dual PPAR-alpha/ activity. This compounds are characterized by their improvement of lipid and glycaemic parameters in plasma, as well as their anti-inflammatory effect with a low or almost absent toxicity.

INDUSTRIAL PROPERTY RIGHTS:

Priority patent application filed in December 2017.

FURTHER INFORMATION:
Quality of Life: Health Promotion and Efficient Health

CONTACT:

INCLIVA Innovation Unit
uai@incliva.es